APA način citiranja

Rugo, H. S., Trédan, O., Ro, J., Morales, S. M., Campone, M., Musolino, A., . . . Baselga, J. (2017). A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer. Breast Cancer Res Treat.

Čikaški stil citiranja

Rugo, Hope S., et al. "A Randomized Phase II Trial of Ridaforolimus, Dalotuzumab, and Exemestane Compared With Ridaforolimus and Exemestane in Patients With Advanced Breast Cancer." Breast Cancer Res Treat 2017.

MLA način citiranja

Rugo, Hope S., et al. "A Randomized Phase II Trial of Ridaforolimus, Dalotuzumab, and Exemestane Compared With Ridaforolimus and Exemestane in Patients With Advanced Breast Cancer." Breast Cancer Res Treat 2017.